Sign in
TerminatedPhase 2

Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers

Key facts

Who runs it
caterina P minniti
Where
Durham, Pittsburgh, and The Bronx, United StatesSee the 3 sites
Trial code
Status
Terminated
Phase
Phase 2
People taking part
18 people enrolled
Started
6 Apr 2018
Ended
24 Nov 2023
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Topical Sodium Nitrite
  • Placebo
Record updated
7 May 2025
Why it stopped
Study terminated prior to achieving target enrollment due to slow recruitment and high cost of obtaining new study drug. Since no additional funds were to be available due to end of the funding period, remaining funds were expended on analyses.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Subjects must have a diagnosis of sickle cell disease (SS, SC, Sß-thalassemia, SD, SOArab)
  • Have one or more ulcers of the one or both leg or foot
  • Total surface area of leg ulcer(s) that will receive treatment must be no larger than 100 cm2
  • No history of congenital methemoglobinemia
  • Have documented normal Glucose-6-Phosphate Dehydrogenase (G6PD) activity

Who cannot take part

  • Patients who are currently enrolled in any other investigational drug study (this does not include observational or natural history protocols)
  • Use of Phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, 4 days prior to screening
  • The following list of drugs and agents may cause methemoglobinemia and should be avoided while on this study:; Anesthetics (local): Benzocaine, procaine, prilocaine, Anbesol, Orajel Antimalarials: chloroquine, primaquine, quinacrine Aniline dyes Chlorates Dapsone Diarylsulfonylureas Doxorubicin Metoclopramide Nitric and nitrous oxide Nitrobenzenes (shoe and floor polish and in paint solvents) Nitroethane (artificial nail remover, propellant, fuel additive) Nitrofurantoin (furadantin) Pyridium (phenazopyridine) Phenacetin Phenylhydrazine Rasburicase Sulfonamides (sulfacetamide, sulfamethoxazole, sulfanilamide, sulfapyridine)
  • Subjects presenting with clinically diagnosed bacterial infection (e.g., osteomyelitis, pneumonia, sepsis or meningitis)
  • Pregnant women - urine or serum Human chorionic gonadotropin (hCG)+ or nursing mothers
  • Exposure to therapeutic nitric oxide, L-arginine, nitroprusside or nitroglycerine within the past 1 week
  • Subjects who have a pre-existing methemoglobinemia (more than 3.5% on two different occasions)

Where in United States

  • Duke University Medical CenterDurham, United States
  • University of PittsburghPittsburgh, United States
  • Montefiore Medical Center-Albert Einstein College of MedicineThe Bronx, United States

About the trial

What the trial wants to find out

The investigators are conducting a Phase II prospective and placebo controlled study of a topical cream containing sodium nitrite compared to the current standard of care. Sodium nitrite is a local donor of nitric oxide, which is known to improve blood flow and decrease bacterial load in the ulcer bed. The primary objectives are to evaluate the safety of topical sodium nitrite cream treatment in patients with sickle cell disease and chronic leg ulcers and to determine its effectiveness in accelerating the healing process and decreasing the pain associated with ulceration.

Read full original descriptionShow less

Potential benefit will be a durable resolution or improvement of the leg ulcer and its associated pain. Possible side effects include decreased blood pressure and methemoglobinemia, secondary to sodium nitrite absorption through the ulcerated skin.

Funding source FDA OOPD.

The 2 groups in the trial

  • controlPlacebo, for comparison

    patients will receive placebo and standard of care

    Treatment: Placebo

  • topical sodium nitriteTreatment being tested

    patients will receive 2% topical sodium nitrite cream and standard of care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase II Study of Topical Sodium Nitrite in Patients With Sickle Cell and Leg Ulcers
Record updated
7 May 2025